• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Essilor promotes new Crizal lens coating in the UK


The new anti-reflective lens coating outperforms its predecessors by up to 70%

Essilor has launched a new generation of its Crizal coating and multi-pair promotion in the UK. The new, anti-reflective coating, named the Sapphire HR, includes several durability enhancements.

Sapphire HR underwent a number of life proof tests in development, including an abrasion resistance test and a multi-angular reflection test, according to the company. The resulting coating is 70% more scratch resistant and up to 20% more thermal resistant than its predecessors.

“ECPs can be confident about offering a solution to shield patients’ eyes and their lenses against obstructions for a long-lasting transparency, with the promise of durability, ease of care, and UV protection,” said Tim Precious, managing director at Essilor Ltd.

For independent optical practices, Essilor has launched a 2022 take two promotion with all branded lenses including Stellest, Eyezen Kids, Varilux and Transitions in the UK. The second pair purchased is either discounted by up to 50% or free dependent on the product chosen.

The take two promotion took effect February 1, 2022 and will remain active until December 2022.

Related Videos
Charles Leclercq, CEO of ARxVision, details the new ARx AI headset and its uses
Chris and Jamie Shyer, Zyloware Eyewear co-CEOs, after their NOW Optical Lifetime Achievement award win at Vision Expo East
The Vision Council CEO Ashley Mills gives a preview of the 2024 Vision Expo East event
Eric Fazio, OD, talks EVO ICLs versus LASIK for patients in interview with Optometry Times
Shalu Pal, BSc, OD, FAAO
© 2024 MJH Life Sciences

All rights reserved.